Merit Medical Systems (MMSI) Q1 Earnings: What To Expect

Medical device company Merit Medical Systems (NASDAQ:MMSI) will be announcing earnings results tomorrow after the bell. Here’s what investors should know.

Merit Medical Systems beat analysts’ revenue expectations by 1% last quarter, reporting revenues of $355.2 million, up 9.4% year on year. It was a mixed quarter for the company, with a solid beat of analysts’ EPS estimates but a significant miss of analysts’ full-year EPS guidance estimates.

Is Merit Medical Systems a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Merit Medical Systems’s revenue to grow 9% year on year to $352.7 million, in line with the 8.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.75 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Merit Medical Systems has missed Wall Street’s revenue estimates twice over the last two years.

Looking at Merit Medical Systems’s peers in the healthcare equipment and supplies segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Intuitive Surgical delivered year-on-year revenue growth of 19.2%, beating analysts’ expectations by 3.1%, and Boston Scientific reported revenues up 20.9%, topping estimates by 2%.

Read our full analysis of Intuitive Surgical’s results here and Boston Scientific’s results here.

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.